Scientists, clinicians, and other investigators are discovering new uses for drugs previously known for different medical indications. Such “drug repurposing” (also called drug repositioning, profiling, or re-tasking) has...more
10/5/2020
/ Actavis Inc. ,
Coronavirus/COVID-19 ,
Eli Lilly ,
Intellectual Property Protection ,
Investment Opportunities ,
Investment Products ,
IP License ,
Marketing Exclusivity Periods ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Prescription Drugs ,
Treatment Method Patents
Avoiding Common IP Pitfalls: What Every Startup Needs to Know -
Startup companies often face significant risk and liability with respect to Intellectual Property (IP) on their path to success. The failure to adequately...more
Even with billions of dollars of funding and the cumulative knowledge and experience of over a hundred years of experimental pharmacology, de novo discovery of effective and safe therapeutics remains a costly and risky...more